NCT00860015View on ClinicalTrials.gov

Alimta Plus Gemcitabine for Advanced Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

April 30, 2012

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

Alimta

"500 mg/m2 via IV over 10 minutes~A chemotherapy drug with indications to treat pleural mesothelioma and non-small cell lung cancer."

DRUG

Gemcitabine

"1000 mg/m2 via IV over 90 minutes~A nucleoside analog used as chemotherapy."

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00860015 - Alimta Plus Gemcitabine for Advanced Sarcoma | Biotech Hunter | Biotech Hunter